Showing 1871-1880 of 4064 results for "".
Primary Care Takeaways From VESALIUS-CV: Evolocumab Efficacy in Patients Without Significant Atherosclerosis
https://reachmd.com/clinical-practice/cardiology/primary-care-takeaways-from-vesalius-cv-evolocumab-efficacy-in-patients-without-significant-atherosclerosis/56623/Evolocumab reduced CV events even without atherosclerosis. Dr. Morales explores what earlier LDL-C lowering means for primary care.Do Not Delay: Timing, Triggers, and Identifying the Right Patient for Additional Therapies in HFrEF
https://reachmd.com/programs/cme/do-not-delay-timing-triggers-and-identifying-the-right-patient-for-additional-therapies-in-hfref/54633/Drs. Bauersachs, Butler & Lam discuss persistent residual risk in HFrEF, the use of sGC stimulators to reduce risk, and supporting evidence for this approach.The Prognostic Utility of Neurofilament Light Chain in Multiple Sclerosis: A Narrative Review
https://reachmd.com/diseases-diagnoses/ms-immune-disorders/the-prognostic-utility-of-neurofilament-light-chain-in-multiple-sclerosis-a-narrative-review/32098/Neurofilament light chain has great promise as a prognostic biomarker in multiple sclerosis.Psoriasis and Obesity: Going Pound for Pound on Comprehensive, Patient-Centered Management
https://reachmd.com/programs/cme/psoriasis-and-obesity-going-pound-for-pound-on-comprehensive-patient-centered-management/39671/On-demand webcast of expert faculty presentation on the key connection between psoriasis and obesity, including comprehensive treatment strategies that consider outcomes improvement for both diseases.Subcutaneous Pembrolizumab in mNSCLC: A Potential Shift in the Delivery Landscape
https://reachmd.com/programs/project-oncology/subcutaneous-pembrolizumab-in-mnsclc-a-potential-shift-in-the-delivery-landscape/36398/Chikungunya Virus: A Look at Prevention Strategies and Vaccine Innovations
https://reachmd.com/programs/vaccination/chikungunya-virus-a-look-at-prevention-strategies-and-vaccine-innovations/26488/Here’s how we can keep our patients traveling abroad safe from the chikungunya virus using a novel vaccine and other preventive strategies.MH Risk Factors After RRD Repair
https://reachmd.com/clinical-practice/ophthalmology/mh-risk-factors-after-rrd-repair/54289/Why do some patients develop macular hole (MH) after rhegmatogenous retinal detachment (RRD) repair? In this episode of Clinical Minute: Retina, host Maria Berrocal, MD, speaks with Avni Finn, MD, about a case-controlled study exploring potential risk factors for MH following RRD surgery. They examiRise in Early-Onset Colon Cancer Being Studied Through Single-Cell Sequencing
https://reachmd.com/programs/medical-industry-feature/rise-in-early-onset-colon-cancer-being-studied-through-single-cell-sequencing/29922/What’s behind the rise in colon cancer in younger patients? Listen to a breakdown of key trends, possible causes, and ongoing research to find answers.Key Considerations for G-CSF Administration in Patients with FN Risk
https://reachmd.com/programs/medical-industry-feature/key-considerations-for-g-csf-administration-in-patients-with-fn-risk/13123/Here’s what you need to keep in mind when administering granulocyte colony stimulating factors for primary prophylaxis of febrile neutropenia.Behind the Screens: Innovations in Type 1 Diabetes Clinical Trials—From Immunomodulation to Screening Strategies and Advanced Cell Therapies
https://reachmd.com/programs/cme/behind-the-screens-innovations-in-type-1-diabetes-clinical-trialsfrom-immunomodulation-to-screening-strategies-and-advanced-cell-therapies/39701/Behind the Screens: Innovations in Type 1 Diabetes Clinical Trials—From Immunomodulation to Screening Strategies and Advanced Cell Therapies